Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule belonging to the phenylpyrimidine class. It has been catalogued in chemical and drug databases as an experimental or research compound with no approved medical indications. Its structure features a pyrazolopyrimidine core substituted with phenyl and pyridin-methylamino groups as well as a methanol moiety. There is no published information on its mechanism of action or biological targets in humans; it appears primarily in structural biology resources (e.g., PDB ligand 2SC), suggesting use as a tool compound or crystallographic ligand rather than a developed pharmaceutical agent.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol.